|
CA2309688C
(en)
*
|
1997-11-10 |
2007-04-24 |
Cellegy Pharmaceuticals, Inc. |
Penetration enhancing and irritation reducing systems
|
|
US7029694B2
(en)
*
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
AU5378201A
(en)
*
|
2000-04-26 |
2001-11-07 |
Watson Pharmaceuticals Inc |
Minimizing adverse experience associated with oxybutynin therapy
|
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
US7897559B2
(en)
*
|
2000-06-29 |
2011-03-01 |
Parks L Dean |
Dermatological composition and kit containing avermectin compound for treating dermatological conditions
|
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
CA2418135C
(en)
|
2000-08-03 |
2011-09-20 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
|
US6503894B1
(en)
*
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
US20030139384A1
(en)
*
|
2000-08-30 |
2003-07-24 |
Dudley Robert E. |
Method for treating erectile dysfunction and increasing libido in men
|
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
|
KR20030048021A
(ko)
*
|
2000-08-30 |
2003-06-18 |
유니메드 파마슈티칼스, 인크. |
여성의 테스토스테론 및 관련된 스테로이드의 농도를증가시키는 방법
|
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
|
ES2341090T3
(es)
*
|
2000-08-30 |
2010-06-15 |
Unimed Pharmaceuticals, Llc |
Procedimiento para tratar la disfuncion erectil y aumentar la libido en hombres.
|
|
JP5039252B2
(ja)
*
|
2000-08-31 |
2012-10-03 |
ユニメッド ファーマシューティカルズ,リミティド ライアビリティ カンパニー |
性機能低下を治療するための医薬組成物及び方法
|
|
HRP20030510A2
(en)
*
|
2000-12-22 |
2005-04-30 |
Dr. August Wolff Gmbh & Co. Arzneimittel |
Gel composition and trans-scrotal application of acomposition for the treatment of hypogonadism
|
|
TWI331522B
(en)
*
|
2001-06-22 |
2010-10-11 |
Cpex Pharmaceuticals Inc |
Pharmaceutical composition
|
|
WO2003015789A2
(en)
*
|
2001-08-15 |
2003-02-27 |
Leo Pharma A/S |
A pharmaceutical composition for dermal application
|
|
US20030175329A1
(en)
*
|
2001-10-04 |
2003-09-18 |
Cellegy Pharmaceuticals, Inc. |
Semisolid topical hormonal compositions and methods for treatment
|
|
AU2002366800B2
(en)
|
2001-12-20 |
2006-08-03 |
Femmepharma Holding Company, Inc. |
Vaginal delivery of drugs
|
|
MXPA04008988A
(es)
*
|
2002-03-15 |
2006-05-25 |
Unimed Pharmaceuticals Inc |
Composicion androgena farmaceutica y metodo para el tratamiento de la depresion.
|
|
BR0308584A
(pt)
*
|
2002-03-15 |
2005-02-22 |
Unimed Pharmaceuticals Inc |
Composição farmacêutica androgênica e método para tratamento de depressão
|
|
MY139721A
(en)
|
2002-04-19 |
2009-10-30 |
Cpex Pharmaceuticals Inc |
Pharmaceutical composition
|
|
US6959640B2
(en)
*
|
2002-06-06 |
2005-11-01 |
Omega Patents, L.L.C. |
Device for magnetically treating materials and associated methods
|
|
WO2004000263A1
(en)
|
2002-06-25 |
2003-12-31 |
Acrux Dds Pty Ltd |
Transdermal delivery rate control using amorphous pharmaceutical compositions
|
|
US7099713B2
(en)
|
2002-06-28 |
2006-08-29 |
Battelle Memorial Institute |
Skin conduction and transport systems
|
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
|
US20060140984A1
(en)
|
2002-10-25 |
2006-06-29 |
Foamix Ltd. |
Cosmetic and pharmaceutical foam
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
|
US9173836B2
(en)
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
|
US7812010B2
(en)
|
2003-01-02 |
2010-10-12 |
Femmepharma, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
|
USD511198S1
(en)
|
2003-02-18 |
2005-11-01 |
Omega Patents, L.L.C. |
Magnetic treatment device for fluids
|
|
USD500118S1
(en)
|
2003-02-18 |
2004-12-21 |
Omega Patents, L.L.C. |
Magnetic treatment device for fluids
|
|
EP1594545B1
(de)
*
|
2003-02-20 |
2008-11-12 |
Besins International Belgique |
Pharmazeutische zubereitung zur transdermalen und transmukosen verabreichung
|
|
FR2851470B1
(fr)
*
|
2003-02-20 |
2007-11-16 |
Besins Int Belgique |
Composition pharmaceutique pour administration transdermique ou transmuqueuse
|
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
|
US20040259852A1
(en)
*
|
2003-06-18 |
2004-12-23 |
White Hillary D. |
Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
|
|
US8883769B2
(en)
*
|
2003-06-18 |
2014-11-11 |
White Mountain Pharma, Inc. |
Methods for the treatment of fibromyalgia and chronic fatigue syndrome
|
|
US20050037040A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of urea and ammonium lactate
|
|
US20050042182A1
(en)
*
|
2003-08-13 |
2005-02-24 |
Moshe Arkin |
Topical compositions of urea
|
|
US20050036953A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of ammonium lactate
|
|
FR2856926B1
(fr)
*
|
2003-07-02 |
2005-09-30 |
Centre Nat Rech Scient |
Utilisation des n-alkanols comme activateurs du canal cftr
|
|
US20050020552A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
US20050025833A1
(en)
*
|
2003-07-16 |
2005-02-03 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
US20050042268A1
(en)
*
|
2003-07-16 |
2005-02-24 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
|
CA2538856C
(en)
|
2003-10-10 |
2010-06-29 |
Antares Pharma Ipl Ag |
Transdermal pharmaceutical formulation for minimizing skin residues
|
|
US20070191815A1
(en)
|
2004-09-13 |
2007-08-16 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
|
US20050244502A1
(en)
*
|
2004-04-28 |
2005-11-03 |
Mathias Neil R |
Composition for enhancing absorption of a drug and method
|
|
US7425340B2
(en)
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
|
EP1634583A1
(de)
*
|
2004-09-09 |
2006-03-15 |
Laboratoires Besins International |
Testosterongele enthaltend Propylenglykol als Resorptionsverstärker
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
US20070042026A1
(en)
*
|
2005-03-17 |
2007-02-22 |
Wille John J |
Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
|
|
WO2007124250A2
(en)
|
2006-04-21 |
2007-11-01 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
|
US8372040B2
(en)
|
2005-05-24 |
2013-02-12 |
Chrono Therapeutics, Inc. |
Portable drug delivery device including a detachable and replaceable administration or dosing element
|
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
|
KR20130114229A
(ko)
|
2005-06-03 |
2013-10-16 |
애크럭스 디디에스 피티와이 리미티드 |
경피 약물 전달 방법 및 조성물
|
|
GB0518558D0
(en)
*
|
2005-09-12 |
2005-10-19 |
Givaudan Sa |
Improvements in or related to organic compounds
|
|
RS52671B
(sr)
|
2005-10-12 |
2013-06-28 |
Unimed Pharmaceuticals Llc |
Poboljšani gel testosterona i postupak korišćenja
|
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
|
EP2104489A2
(de)
*
|
2006-12-26 |
2009-09-30 |
FemmePharma Holding Company, Inc. |
Topische verabreichung von danazol
|
|
EA015473B1
(ru)
|
2007-01-11 |
2011-08-30 |
АКРУКС ДиДиЭс ПиТиУай ЭлТиДи |
Инструмент для нанесения объема жидкости на обрабатываемую поверхность, система и способ трансдермального введения физиологически активного вещества в организм больного
|
|
US9283177B2
(en)
*
|
2007-01-16 |
2016-03-15 |
Juventio, Llc |
Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
|
|
US8759391B2
(en)
*
|
2007-01-16 |
2014-06-24 |
Juventio, Llc |
Topical anesthetic for rapid local anesthesia
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
|
AU2009205314A1
(en)
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
|
KR20100113075A
(ko)
*
|
2008-05-21 |
2010-10-20 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
비스테로이드성 항염증제의 경피 투여를 통한 생리통의 치료 방법
|
|
CA2730787A1
(en)
*
|
2008-07-16 |
2010-01-21 |
David M. Cohen |
Topical drug delivery system
|
|
CA2738970A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Moberg Derma Ab |
Topical composition comprising a combination of at least two penetration enhancing agents
|
|
ES2624557T3
(es)
*
|
2008-12-11 |
2017-07-14 |
Besins Healthcare Luxembourg Sarl |
Composiciones farmacéuticas transdérmicas que comprenden un SERM
|
|
US20120087872A1
(en)
|
2009-04-28 |
2012-04-12 |
Foamix Ltd. |
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
|
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
WO2011022652A1
(en)
|
2009-08-21 |
2011-02-24 |
Novan, Inc. |
Topical gels
|
|
AU2010302350B2
(en)
|
2009-10-02 |
2015-06-18 |
Journey Medical Corporation |
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
|
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
|
US10080760B2
(en)
|
2009-10-27 |
2018-09-25 |
Besins Healthcare Luxembourg Sarl |
Transdermal pharmaceutical compositions comprising active agents
|
|
US8174881B2
(en)
|
2009-11-24 |
2012-05-08 |
Micron Technology, Inc. |
Techniques for reducing disturbance in a semiconductor device
|
|
US12661407B2
(en)
|
2010-04-08 |
2026-06-23 |
Journey Medical Corporation |
Compositions, gels and foams with rheology modulators and uses thereof
|
|
CN102309669B
(zh)
*
|
2010-07-08 |
2013-07-03 |
高健生 |
一种治疗变态反应性结膜炎的中药制剂
|
|
US9642862B2
(en)
|
2010-11-18 |
2017-05-09 |
White Mountain Pharma, Inc. |
Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein
|
|
US20130040923A1
(en)
|
2011-05-13 |
2013-02-14 |
Trimel Pharmaceuticals Corporation |
Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
|
US9757388B2
(en)
|
2011-05-13 |
2017-09-12 |
Acerus Pharmaceuticals Srl |
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
|
|
US20130045958A1
(en)
|
2011-05-13 |
2013-02-21 |
Trimel Pharmaceuticals Corporation |
Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
|
MX2013013369A
(es)
*
|
2011-05-15 |
2014-10-17 |
Trimel Biopharma Srl |
Formulaciones de gel bioadhesivo de testosterona intranasal y uso del mismo para tratar hipogonadismo masculino.
|
|
ES2804263T3
(es)
|
2011-07-05 |
2021-02-05 |
Novan Inc |
Composiciones tópicas
|
|
US20130017259A1
(en)
|
2011-07-06 |
2013-01-17 |
The Parkinson's Institute |
Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
|
|
CN102335390B
(zh)
*
|
2011-09-30 |
2013-01-02 |
王巍 |
一种治疗面部湿疹的洗剂
|
|
CN104302175B
(zh)
|
2012-03-14 |
2017-04-12 |
诺万公司 |
释放一氧化氮的药物组合物
|
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
|
US9855211B2
(en)
|
2013-02-28 |
2018-01-02 |
Novan, Inc. |
Topical compositions and methods of using the same
|
|
US11744838B2
(en)
|
2013-03-15 |
2023-09-05 |
Acerus Biopharma Inc. |
Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
|
|
EP3030266B1
(de)
|
2013-08-08 |
2020-10-28 |
Novan Inc. |
Topische zusammensetzungen und verfahren zur verwendung davon
|
|
WO2016022170A1
(en)
|
2014-08-08 |
2016-02-11 |
Novan, Inc. |
Topical emulsions
|
|
USD750788S1
(en)
|
2013-11-26 |
2016-03-01 |
Acrux Dds Pty Ltd |
Topical spreading applicator
|
|
USD749225S1
(en)
|
2013-11-26 |
2016-02-09 |
Acrux Dds Pty Ltd |
Topical spreading applicator
|
|
US8785426B1
(en)
|
2013-12-13 |
2014-07-22 |
Upsher-Smith Laboratories, Inc. |
Testosterone gel compositions and related methods
|
|
ES2807200T3
(es)
|
2014-07-11 |
2021-02-22 |
Novan Inc |
Composiciones antivirales tópicas y procedimientos de uso de las mismas
|
|
US10322082B2
(en)
|
2014-07-11 |
2019-06-18 |
Novan, Inc. |
Topical antiviral compositions and methods of using the same
|
|
JP2018511355A
(ja)
|
2015-01-28 |
2018-04-26 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
薬剤送達方法及びシステム
|
|
AU2016228779A1
(en)
|
2015-03-12 |
2017-09-07 |
Chrono Therapeutics Inc. |
Craving input and support system
|
|
US20170014417A1
(en)
|
2015-07-14 |
2017-01-19 |
Lipp Life Sciences Llc |
Pharmaceutical administration system for the transdermal application of vardenafil
|
|
CN107949389A
(zh)
*
|
2015-09-30 |
2018-04-20 |
富士胶片株式会社 |
经皮吸收用组合物
|
|
WO2017151905A1
(en)
|
2016-03-02 |
2017-09-08 |
Novan, Inc. |
Compositions for treating inflammation and methods of treating the same
|
|
CN109310630A
(zh)
|
2016-04-13 |
2019-02-05 |
诺万公司 |
用于治疗感染的组合物、系统、试剂盒和方法
|
|
MX2020012139A
(es)
|
2016-09-08 |
2021-01-29 |
Vyne Pharmaceuticals Inc |
Composiciones y metodos para tratar rosacea y acne.
|
|
WO2018129304A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
US10821075B1
(en)
*
|
2017-07-12 |
2020-11-03 |
James Blanchard |
Compositions for topical application of a medicaments onto a mammalian body surface
|
|
WO2019089755A1
(en)
|
2017-10-31 |
2019-05-09 |
Western Oncolytics Ltd. |
Platform oncolytic vector for systemic delivery
|
|
US11285171B2
(en)
|
2018-03-01 |
2022-03-29 |
Novan, Inc. |
Nitric oxide releasing suppositories and methods of use thereof
|
|
AU2019279884B2
(en)
|
2018-05-29 |
2025-01-30 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
AU2019365255B2
(en)
|
2018-10-26 |
2025-06-12 |
Viramal Limited |
Mucoadhesive gel composition
|
|
JP2022507660A
(ja)
|
2018-11-16 |
2022-01-18 |
モーニングサイド ベンチャー インベストメンツ リミテッド |
温度によって調節される経皮薬剤送達システム
|
|
EP3659583B1
(de)
|
2018-11-30 |
2023-06-07 |
Viramal Limited |
Verfahren zur herstellung eines geliermittels, das dadurch erhaltene geliermittel und verwendung dieses geliermittels
|
|
JP2023552289A
(ja)
|
2020-11-19 |
2023-12-15 |
カリヴィル イムノセラピューティクス, インコーポレイテッド |
腫瘍微小環境リモデリングによる腫瘍溶解性免疫療法
|
|
EP4329786A4
(de)
|
2021-04-30 |
2024-12-11 |
KaliVir Immunotherapeutics, Inc. |
Onkolytische viren zur modifizierten mhc-expression
|